A statin for a patient with hyperlipidemia and hepatitis C?
Nash
David T
DT
State University of New York, Health Science Center, Syracuse College of Medicine, USA.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000069059:Atorvastatin; D001384:Azetidines / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004032:Diet; D015444:Exercise; D000069438:Ezetimibe; D019698:Hepatitis C, Chronic / Q000150:complications*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use; D012307:Risk Factors
D000924:Anticholesteremic Agents; D001384:Azetidines; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D002792:Cholestyramine Resin; D000069059:Atorvastatin; D000069438:Ezetimibe